The largest database of trusted experimental protocols

21 protocols using as 4050

1

HPLC-FLD Quantification of Mycotoxin OTA

Check if the same lab product or an alternative is used in the 5 most similar protocols
OTA was quantified
with the previously reported HPLC-FLD method,48 (link) employing an integrated HPLC system (Jasco, Tokyo, Japan): autosampler
(AS-4050), binary pump (PU-4180), fluorescence detector (FP-920),
and ChromNAV2 software. Briefly, the isocratic elution was performed
with 1.0 mL/min flow rate at room temperature, using sodium borate
buffer (0.01 M, pH 10.0) and ACN (87:13 v/v%) as the mobile phase.
Samples (20 μL) were driven through a SecurityGuard precolumn
(C18, 4.0 × 3.0 mm; Phenomenex, Torrance, CA, US) linked to a
Kinetex EVO (C18, 150 × 4.6 mm, 5 μm; Phenomenex) analytical
column. The fluorescence detection of the mycotoxin was carried out
at 383 and 446 nm excitation and emission wavelengths, respectively.
+ Open protocol
+ Expand
2

Quantitative HPLC-DAD Analysis of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chromatographic method was adapted from Tang et al. [32 (link)], with some modifications. The extracts were injected into a Jasco (Tokyo, Japan) HPLC-DAD system, which consisted of a PU-4180 pump, an MD-4015 PDA detector, and an AS-4050 autosampler. The stationary phase was an Agilent (Santa Clara, CA, USA) Zorbax Eclipse Plus C18 reverse-phase column (100 × 3 mm I.D., 3.5 μm). The mobile phase was a mixture of solvent A (water/formic acid 95/5, v/v) and solvent B (methanol/acetonitrile 95/5, v/v), with a composition gradient ranging from 95% to 5% of solvent A and flowing at 0.7 mL/min. Injection volume was 20 µL for all determinations, and analyte detection was carried out with a diode array detector (DAD) by monitoring at 280, 329, and 360 nm. Quantification was performed with pure standards using calibration curves ranging between 1.25 and 30 μg mL−1 (r2 ≥ 0.9634).
+ Open protocol
+ Expand
3

HPLC Analysis of Nicotinic Acid

Check if the same lab product or an alternative is used in the 5 most similar protocols
NIA analysis was conducted using an HPLC equipped with a reversed-phase monolithic column (Chromolith® RP-18e, 100 mm × 4.6 mm i.d., Merck) connected to a Jasco (Easton, PA, USA) HPLC system (pump PU-4180, autosampler AS-4050 and LC-Net II/ADC controller) coupled to a PDA detector (Jasco MD-4010, start wavelength = 200 nm, End Wavelength = 400 nm). The data processing was performed by ChromNAV 2.0 HPLC software (Easton, PA, USA). The chromatogram was acquired at a wavelength of 263 nm, and the retention time of NIA was at 4.8 min. The mobile phase was a mixture of water and methanol (80:20, v/v) and eluted at a flow rate of 1.0 mL/min. The injection volume was set to 20 μL with the column temperature at 30 °C. Prior to use, the mobile phase was degassed in an ultrasonic bath for 30 min. Validation of HPLC method was performed by evaluating linearity, range accuracy, precision, lower limit of quantification (LOQ), and upper limit of detection (LOD) according to established guidelines [43 (link)]. The calculated LOD was 0.18 µg/mL and the LOQ was 0.53 µg/mL.
+ Open protocol
+ Expand
4

Quantification of Ochratoxin A by HPLC

Check if the same lab product or an alternative is used in the 5 most similar protocols
An integrated HPLC system (Jasco, Tokyo, Japan) was applied, which is built up from an autosampler (AS-4050), a binary pump (PU-4180), and a fluorescence detector (FP-920). Chromatographic data were evaluated employing ChromNAV2 software (Jasco, Tokyo, Japan). OTA was quantified as it has been recently reported [55 (link)]. Briefly, samples (20 μL) were driven through a SecurityGuard precolumn (C18, 4.0 × 3.0 mm; Phenomenex, Torrance, CA, USA) linked to a Kinetex EVO-C18 (150 × 4.6 mm, 5 μm; Phenomenex) analytical column with 1.0 mL/min flow rate, at room temperature. Isocratic elution was performed, where sodium borate buffer (10 mM, pH 10.0) and ACN (87:13 v/v%) were applied in the mobile phase. OTA was detected at 446 nm (λex = 383 nm). Samples were measured in triplicates.
The linearity of the method was determined between 10 nmol/L and 1.0 μmol/L (4.0–403.8 μg/L) concentrations (R2 = 0.9996). Limit of detection (2 nmol/L or 0.8 μg/L) and limit of quantification (6 nmol/L or 2.4 μg/L) values were defined as the lowest concentrations when the signal-to-noise ratios reached 3 and 10, respectively. The intraday repeatability was evaluated based on the intraday coefficient of variation (0.55%; n = 7).
+ Open protocol
+ Expand
5

Quantifying Anthocyanins in Plant Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total anthocyanins: The total anthocyanins were determined by the pH differential method according Lee et al. (2005) [46 (link)] by spectrophotometry (spectrophotometer V-700, Jasco, Tokyo, Japan). All analyses were carried out in triplicate.
Anthocyanin profile by HPLC-DAD: Anthocyanin analysis was done in a chromatographic system HPLC consisting of a Jasco interface LC-NetII/ADC with a diode array detector MD-4010 and an autosampler AS-4050 (Jasco, Tokyo, Japan) with a C18 column (Kromasil-100, 3.5 mm i.d × 150 mm). The samples (20 μL) were then injected. The mobile phases, A (0.2% v/v TFA in water), B (0.2% v/v TFA in acetonitrile), and C (0.2% v/v TFA in methanol), were used under the following conditions: initial, 8% B and C maintained for 5 min; an 11 min linear change to 12% B and 7% C; a 12 min linear change to 11.5% B and C; a 20 min linear change to 13.5% B and C; a 25 min linear change to 20% B and C; a 30 min linear change to 50% B and C.
+ Open protocol
+ Expand
6

HPLC-based Warfarin Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
We applied an integrated HPLC system (Jasco, Tokyo, Japan) built up from an autosampler (AS-4050), a binary pump (PU-4180), and a fluorescence detector (FP-920). Chromatographic data were evaluated employing ChromNAV2 software (Jasco, Tokyo, Japan). WAR concentrations were quantified using the previously reported method [35 (link),50 (link)]. Briefly, samples (20 μL) were driven through a guard column (SecurityGuard C18, 4.0 × 3.0 mm; Phenomenex, Torrance, CA, USA) linked to a Nova-Pak C18 analytical column (150 × 3.9 mm, 4 μm; Waters, Milford, MA, USA). The isocratic elution was performed at room temperature with 1.0 mL/min flow rate applying sodium phosphate buffer (20 mM, pH 7.0), methanol, and acetonitrile (70:25:5 v/v%) as the mobile phase. WAR was detected at 390 nm (λex = 310 nm).
+ Open protocol
+ Expand
7

HPLC Quantification of Taro Oxalates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oxalic acid was quantified using high‐performance liquid chromatography (HPLC).23 To extract soluble and total oxalates, taro powder was mixed with distilled water and 0.5 mol L–1 hydrochloride solution (20 mg mL−1). Samples were vortexed (Se‐08, Taitec, Saitama, Japan) and sonicated for 30 min each and centrifuged at 1600×g for 10 min (Model 3500, Kubota, Tokyo, Japan). The supernatant was collected and filtered through a 0.45 μm filter (DISMIC®‐13HP045AN, Advantec) and used as the sample for analysis. The HPLC unit comprised a pump (PU‐4180, Jasco, Japan), a detector (UV‐4075, Jasco, Tokyo, Japan), an autosampler (AS‐4050, Jasco, Tokyo, Japan), and a column oven (SLC‐25A, MEE, Japan). The HPLC analysis was performed using a C18 reversed‐phase column (Cosmosil 5C18‐PAQ, 4.6 mm I.D. × 250 mm, Nacalai Tesque, Kyoto, Japan) maintained at 40 °C. The eluent used was 20 mM phosphate buffer (pH 2.5) with a flow rate of 1.0 mL min−1, a detection wavelength at 254 nm, and an injection volume of 10 μL. The calibration curve was obtained using oxalic acid anhydride (Wako, Japan) as standards (0, 31.3, 62.5, 125, 250, 500, and 1000 μg mL−1, n = 3). Insoluble oxalate was calculated as the difference between the total and soluble oxalates.
+ Open protocol
+ Expand
8

HPLC Analysis of SZV 1287 and Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
The method was described in detail in a recent publication [24 (link)]. Briefly, the threefold volume of ACN was added to a 50 μL aliquot of plasma samples. After vortexing and centrifugation (10 min, 14,000× g, 4 °C), the supernatants were diluted with water then directly injected into the HPLC. Samples were analyzed using an HPLC system (Jasco, Tokyo, Japan), which included an autosampler (AS-4050), a binary pump (PU-4180), and a fluorescence detector (FP-920); the chromatograms were evaluated employing ChromNAV software. Samples (20 μL) were driven through a Security Guard™ (C18, 4.0 × 3.0 mm; Phenomenex, Torrance, CA, USA) guard column linked to a Gemini NX-C18 (150 × 4.6 mm, 3 μm; Phenomenex, Torrance, CA, USA) analytical column with a 1.0 mL/min flow rate, at room temperature. The eluent contained ACN and sodium phosphate buffer (10 mM, pH 7.0) (30:70 v/v% in eluent A, and 55:45 v/v% in eluent B). We applied 100% eluent A from 0 to 4 min, then the eluent was linearly changed to 100% eluent B from 4.0 to 4.5 min, after which 100% eluent B was used from 4.5 to 14.9 min. SZV 1287 and its metabolites (oxaprozin, L 2799, L 2805, and L 2811) were detected applying 320 and 368 nm excitation and emission wavelengths, respectively. Solutions applied for the calibration curves were freshly prepared and diluted every day. The calibration curves showed good linearity (R2 > 0.99).
+ Open protocol
+ Expand
9

HPLC Analysis of Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
HPLC analysis was conducted on a JASCO® equipment with a reverse-phase C-18 column (LiChroCART® 250-4, LiChrosorb®, RP-18, 250 mm × 4 mm, 5 µm), a DAD (MD-4010, Jasco®, Oklahoma City, OK, USA), an autosampler (AS-4050, Jasco®, Oklahoma City, OK, USA), and a pump (PU-4180, Jasco®, Oklahoma City, OK, USA). ChromNav® 2.0 was the software employed for data acquisition and analysis, which was set at room temperature with an injection volume of 10 µL. Detection was performed at 254 and 368 nm. Different mobile phase mixtures were evaluated in an isocratic elution. Previously purified water was filtered with a 0.22 µm nylon filter, and all solvents were degassed by ultrasound. A ratio of 55:40:5 of water/acetonitrile/methanol, acidified with 1.5% acetic acid, was used as the mobile phase. The flow rate was as follows: 1.000 (0–3.5 min), 1.300 (3.5–8 min), and 1.000 (8 min until analysis finale) mL/min. The chromatographic run was set for 10 min.
+ Open protocol
+ Expand
10

Synthesis and Purification of 3-Ga Nanoparticles for In Vivo Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
3-Ga used for Apo-transferrin
coated NPs was prepared using a previously reported procedure.14 (link),33 (link) In short, commercially available chemicals were purchased from Sigma-Aldrich,
Merck, and Chem Intel and used as received unless otherwise stated.
Apo-transferrin is from Sigma-Aldrich (St. Louis, MO, US). Analytical
reagent (AR)-grade solvents were used for the reactions and column
chromatography. Pyrrole was subjected to filtration using a column
packed with neutral aluminum oxide before use, while the remaining
reagents were employed without further purification. Unless otherwise
stated, synthesis was performed in ambient conditions. Produced 3-Ga for in vivo studies was recrystallized
in DCM/hexanes 1:1 and washed with cold hexanes for maximal purity.
HPLC analysis was performed on a combination of a JASCO organizer,
a diode array detector MD-4010, an autosampler AS-4050, and an RHPLC
pump PU4180. Silica gel (230–400 mesh) used for column chromatography
was obtained from E. Merck Ltd. Either flash or preparative thin-layer
chromatography was performed to purify the compounds. A purity of
>97% for 3-Ga was determined with HPLC and UV detection
at their Soret band region; a summary of the HPLC result and the HPLC
condition of 3-Ga is shown in the Supporting Information
(Figure S12–S14).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!